Literature DB >> 11207645

Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.

V Hána1, M Dokoupilová, J Marek, R Plavka.   

Abstract

A 17-year-old primigravid woman presented with Cushing's syndrome. Typical clinical symptoms and signs developed at the beginning of pregnancy. By week 17 of gestation, plasma cortisol diurnal rhythm was absent and there was a paradoxical increase in plasma cortisol after a 1-mg dexamethasone overnight suppression test. Basal urinary free cortisol was 10 times above the upper limit (in pregnancy) and ACTH levels were suppressed. The diagnosis of ACTH--independent Cushing's syndrome was established. MRI scans revealed normal adrenal and pituitary glands. To control hypercortisolism, the patient was treated with metyrapone. At 34 weeks of gestation, the patient developed preeclampsia and underwent caesarean section. A female infant weighing 1070 g was delivered. No apparent metyrapone-induced teratogenic effects were observed. Cushing's syndrome in the patient resolved within three weeks of delivery. No corticosteroid replacement therapy either for child or mother was needed. Eight months after delivery the patient became pregnant again and rapidly developed Cushing's syndrome with typical clinical symptoms and signs and laboratory results (urinary free cortisol 6464 nmol/24 h). This second pregnancy was unwanted and terminated by artificial abortion that was followed by rapid resolution of hypercortisolism. A third pregnancy, 12 months after delivery was also accompanied by the rapid development of hypercortisolism which recovered after artificial termination. The mechanisms by which pregnancy-induced Cushing's syndrome occurred in this patient are unclear. Aberrant responsiveness or hyperresponsiveness of adrenocortical cells to a non-ACTH and non-CRH substance produced in excess in pregnancy should be considered. Metyrapone suppression of hypercortisolism currently represents the best treatment for these rare cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207645     DOI: 10.1046/j.1365-2265.2001.01055.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  19 in total

Review 1.  Cushing's syndrome in pregnancy.

Authors:  N Polli; F Pecori Giraldi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

2.  Adrenocorticotropin-independent Cushing's syndrome in pregnancy related to overexpression of adrenal luteinizing hormone/human chorionic gonadotropin receptors.

Authors:  E Rask; E Schvarcz; P Hellman; J Hennings; F A Karlsson; C V Rao
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

Review 3.  Medical management of pituitary adenomas: the special case of management of the pregnant woman.

Authors:  Marcello Delano Bronstein; Luiz Roberto Salgado; Nina Rosa de Castro Musolino
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

4.  Prenatal metyrapone treatment modulates neonatal cerebrovascular structure, function, and vulnerability to mild hypoxic-ischemic injury.

Authors:  P Naomi Franco; Lara M Durrant; Desirelys Carreon; Elizabeth Haddad; Adam Vergara; Catherine Cascavita; Andre Obenaus; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

Review 5.  Management of pituitary tumors in pregnancy.

Authors:  Marcello D Bronstein; Diane B Paraiba; Raquel S Jallad
Journal:  Nat Rev Endocrinol       Date:  2011-03-15       Impact factor: 43.330

6.  Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy.

Authors:  C Blanco; E Maqueda; J A Rubio; A Rodriguez
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

7.  Case report: Adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome.

Authors:  Michael Herman Chui; Michael Herman Chui; Nese Colak Ozbey; Shereen Ezzat; Yersu Kapran; Yesim Erbil; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 8.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

9.  THE MULTIFARIOUS CUSHING'S - LESSONS FROM A CASE SERIES.

Authors:  I Ilie; V Ciubotaru; A Tulin; D Hortopan; A Caragheorgheopol; M Purice; C Neamtu; V I Elian; A Banica; L Oprea; M Musat
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

10.  Maternal stress during pregnancy increases neonatal allergy susceptibility: role of glucocorticoids.

Authors:  Robert Lim; Alexey V Fedulov; Lester Kobzik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-16       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.